Literature DB >> 17396290

Posaconazole.

Carol A Kauffman, Anurag N Malani, Chris Easley, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396290     DOI: 10.1038/nrd2270

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.

Authors:  Chiung-Kuang Chen; Siegfried S F Leung; Christophe Guilbert; Matthew P Jacobson; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

Review 2.  Current concepts in antifungal pharmacology.

Authors:  Russell E Lewis
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

3.  Enantioselective synthesis of 2,2-disubstituted tetrahydrofurans: palladium-catalyzed [3+2] cycloadditions of trimethylenemethane with ketones.

Authors:  Barry M Trost; Dustin A Bringley
Journal:  Angew Chem Int Ed Engl       Date:  2013-03-12       Impact factor: 15.336

Review 4.  Posaconazole : a review of its use in the prophylaxis of invasive fungal infections.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors:  Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

6.  Stability-indicating HPLC method for posaconazole bulk assay.

Authors:  Cássia V Garcia; Gislaine R Costa; Andreas S L Mendez
Journal:  Sci Pharm       Date:  2012-03-12

7.  Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.

Authors:  Shamila S Gunatilleke; Claudia M Calvet; Jonathan B Johnston; Chiung-Kuang Chen; Grigori Erenburg; Jiri Gut; Juan C Engel; Kenny K H Ang; Joseph Mulvaney; Steven Chen; Michelle R Arkin; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31

8.  4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.

Authors:  Claudia M Calvet; Debora F Vieira; Jun Yong Choi; Danielle Kellar; Michael D Cameron; Jair Lage Siqueira-Neto; Jiri Gut; Jonathan B Johnston; Li Lin; Susan Khan; James H McKerrow; William R Roush; Larissa M Podust
Journal:  J Med Chem       Date:  2014-08-19       Impact factor: 7.446

9.  Insights into Ergosterol Peroxide's Trypanocidal Activity.

Authors:  Thuluz Meza-Menchaca; Angel Ramos-Ligonio; Aracely López-Monteon; Abraham Vidal Limón; Leonid A Kaluzhskiy; Tatjana V Shkel; Natallia V Strushkevich; Luis Felipe Jiménez-García; Lourdes Teresa Agredano Moreno; Verónica Gallegos-García; Jorge Suárez-Medellín; Ángel Trigos
Journal:  Biomolecules       Date:  2019-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.